Advertisement

Advertisement

EOLS Stock Latest News

Evolus weakness a buying opportunity, says Mizuho

The FlyEvolus weakness a buying opportunity, says Mizuho

Telix names David Gill chair of the board

PremiumThe Fly

Telix names David Gill chair of the board

14d ago

Evolus: Buy Rating Reiterated on Strong Execution, Raised Guidance and Unchanged $13 Price Target

PremiumRatings

Evolus: Buy Rating Reiterated on Strong Execution, Raised Guidance and Unchanged $13 Price Target

1M ago

Evolus Inc. Earnings Call Signals Confident Growth

PremiumCompany Announcements

Evolus Inc. Earnings Call Signals Confident Growth

1M ago

Evolus reports Q2 EPS (12c), consensus (4c)

PremiumThe Fly

Evolus reports Q2 EPS (12c), consensus (4c)

1M ago

Evolus raises FY26 revenue view to $330M-$337M from $327M-$337M

PremiumThe FlyEvolus raises FY26 revenue view to $330M-$337M from $327M-$337M

1M ago

Evolus Expands Estyme Aesthetic Portfolio into New Markets

Company Announcements

Evolus Expands Estyme Aesthetic Portfolio into New Markets

1M ago

Evolus expands strategic partnership with Symatese to commercialize Estyme

The Fly

Evolus expands strategic partnership with Symatese to commercialize Estyme

1M ago

Evolus Secures U.S. Profhilo Distribution Agreement

PremiumCompany Announcements

Evolus Secures U.S. Profhilo Distribution Agreement

2M ago

Evolus partners with IBSA to develop and market Profhilo in the U.S.

PremiumThe Fly

Evolus partners with IBSA to develop and market Profhilo in the U.S.

2M ago

Evolus Reaffirmed at Buy as Analyst Sees Path to Profitability and Maintains $13 Price Target

PremiumRatings

Evolus Reaffirmed at Buy as Analyst Sees Path to Profitability and Maintains $13 Price Target

3M ago

Evolus Shareholders Elect Directors and Ratify Key Proposals

PremiumCompany Announcements

Evolus Shareholders Elect Directors and Ratify Key Proposals

3M ago

Evolus files $250M mixed securities shelf

PremiumThe FlyEvolus files $250M mixed securities shelf

3M ago

Evolus management to meet virtually with BTIG

The Fly

Evolus management to meet virtually with BTIG

3M ago

Evolus Completes Key NUCEIVA Safety Study, Easing Risk for Aesthetic Toxin Investors

Company Announcements

Evolus Completes Key NUCEIVA Safety Study, Easing Risk for Aesthetic Toxin Investors

4M ago

Evolus announces commercial launch of Estyme in Europe

PremiumThe Fly

Evolus announces commercial launch of Estyme in Europe

4M ago

Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps

PremiumCompany Announcements

Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps

4M ago

Evolus Maintains Buy Rating as Scalable Growth Story Solidifies; $13 Price Target Reaffirmed

PremiumRatings

Evolus Maintains Buy Rating as Scalable Growth Story Solidifies; $13 Price Target Reaffirmed

4M ago

Evolus Earnings Call Highlights Profitable Growth Path

PremiumCompany Announcements

Evolus Earnings Call Highlights Profitable Growth Path

4M ago

Evolus Ends ATM Facility After Strong Q1 Momentum

PremiumCompany AnnouncementsEvolus Ends ATM Facility After Strong Q1 Momentum

4M ago

Evolus reports Q1 EPS (16c), consensus (12c)

The Fly

Evolus reports Q1 EPS (16c), consensus (12c)

4M ago

EOLS Upcoming Earnings Report: What to Expect?

Pre-Earnings

EOLS Upcoming Earnings Report: What to Expect?

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >